Jin Medical International (ZJYL) Gains from Sales and Divestitures (2023 - 2024)
Jin Medical International recorded quarterly Gains from Sales and Divestitures of $2590.0 in Q1 2024, up 395.22% quarter-over-quarter from $523.0 in Q1 2023, and up 395.22% year-over-year from $523.0 in Q2 2023.
Jin Medical International's Gains from Sales and Divestitures history runs 2 years deep, the most recent figure standing at $2590.0 for Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Jin Medical International | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 2,590.00 |
| Mar 31, 2024 | 2,590.00 |
| Mar 31, 2023 | 523.00 |
| Mar 31, 2023 | 523.00 |